Aerovate Therapeutics (AVTE) Expected to Announce Quarterly Earnings on Monday

Aerovate Therapeutics (NASDAQ:AVTE - Get Free Report) is expected to issue its quarterly earnings data before the market opens on Monday, March 24th. Analysts expect the company to announce earnings of ($0.40) per share for the quarter.

Aerovate Therapeutics Trading Down 0.4 %

NASDAQ:AVTE traded down $0.01 during trading hours on Monday, hitting $2.46. The stock had a trading volume of 60,056 shares, compared to its average volume of 581,241. The company has a market cap of $71.03 million, a PE ratio of -0.82 and a beta of 1.01. The business has a 50 day simple moving average of $2.50 and a two-hundred day simple moving average of $2.40. Aerovate Therapeutics has a 1-year low of $1.25 and a 1-year high of $32.42.

Aerovate Therapeutics Company Profile

Aerovate Therapeutics, Inc, a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial.